Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 9 (RPL12P9) is annotated as a processed pseudogene related to the ribosomal protein L12 family[6]. Pseudogenes are segments of DNA, often remnants of once-functional genes that have lost their protein-coding ability or are otherwise no longer expressed in the cell[1][6]. RPL12P9 shares sequence homology with the functional ribosomal protein L12 gene (RPL12), which codes for a component of the 60S ribosomal subunit involved in protein synthesis[1][3]. However, RPL12P9 itself does not encode a functional protein and is not known to have a role in cellular processes, disease association, or therapeutic targeting[6]. RPL12P9 is distinct from the functional RPL12 gene, which encodes the ribosomal protein L12 involved in ribosome assembly and protein synthesis[1][3]. As a pseudogene, RPL12P9 may exist as non-coding DNA or a non-functional transcript and lacks demonstrated biological or clinical utility[6]. It is not referenced as a target for any drug, nor as a marker for disease or patient selection[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 9 (RPL12P9).